• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自肝素黄杆菌的肝素裂解酶的纯化与特性分析

Purification and characterization of heparin lyases from Flavobacterium heparinum.

作者信息

Lohse D L, Linhardt R J

机构信息

Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Iowa, Iowa City 52242.

出版信息

J Biol Chem. 1992 Dec 5;267(34):24347-55.

PMID:1332952
Abstract

Heparin lyase I has been purified from Flavobacterium heparinum and has been partially characterized (Yang, V. C., Linhardt, R. J., Berstein, H., Cooney, C. L., and Langer, R. (1985) J. Biol. Chem. 260, 1849-1857). There has been no report of the purification of the other polysaccharide lyases from this organism. Although all three of these heparin/heparan sulfate lyases are widely used, with the exception of heparin lyase I, there is no information on their purity or their physical and kinetic characteristics. The absence of pure heparin lyases and a lack of understanding of the optimal catalytic conditions and substrate specificity has stood in the way of the use of these enzymes as reagents for the specific depolymerization of heparin and heparan sulfate into oligosaccharides for structure and activity studies. This paper describes a single, reproducible scheme to simultaneously purify all three of the heparin lyases from F. heparinum to apparent homogeneity. Heparin lyase I (heparinase, EC 4.2.2.7), heparin lyase II (no EC number), and heparin lyase III (heparitinase, EC 4.2.2.8) have molecular weights (by sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and isoelectric points (by isoelectric focusing) of M(r) 42,800, pI 9.1-9.2, M(r) 84,100, pI 8.9-9.1, M(r) 70,800, pI 9.9-10.1, respectively. Their amino acid analyses and peptide maps demonstrate that while these proteins are different gene products they are closely related. The kinetic properties of the heparin lyases have been determined as well as the conditions to optimize their activity and stability. These data should improve the application of these important enzymes in the study of heparin and heparan sulfate.

摘要

肝素裂解酶I已从肝素黄杆菌中纯化出来,并已进行了部分特性鉴定(杨,V.C.,林哈特,R.J.,伯恩斯坦,H.,库尼,C.L.,和兰格,R.(1985年)《生物化学杂志》260,1849 - 1857)。尚未有关于从该生物体中纯化其他多糖裂解酶的报道。尽管这三种肝素/硫酸乙酰肝素裂解酶都被广泛使用,但除了肝素裂解酶I外,关于它们的纯度以及物理和动力学特性均无相关信息。缺乏纯的肝素裂解酶以及对最佳催化条件和底物特异性缺乏了解,阻碍了将这些酶用作试剂,将肝素和硫酸乙酰肝素特异性解聚为寡糖以进行结构和活性研究。本文描述了一种单一、可重复的方案,用于同时从肝素黄杆菌中纯化所有三种肝素裂解酶至表观均一性。肝素裂解酶I(肝素酶,EC 4.2.2.7)、肝素裂解酶II(无EC编号)和肝素裂解酶III(类肝素酶,EC 4.2.2.8)的分子量(通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳)和等电点(通过等电聚焦)分别为M(r) 42,800,pI 9.1 - 9.2、M(r) 84,100,pI 8.9 - 9.1、M(r) 70,800,pI 9.9 - 10.1。它们的氨基酸分析和肽图表明,虽然这些蛋白质是不同的基因产物,但它们密切相关。已确定了肝素裂解酶的动力学性质以及优化其活性和稳定性的条件。这些数据应能改善这些重要酶在肝素和硫酸乙酰肝素研究中的应用。

相似文献

1
Purification and characterization of heparin lyases from Flavobacterium heparinum.来自肝素黄杆菌的肝素裂解酶的纯化与特性分析
J Biol Chem. 1992 Dec 5;267(34):24347-55.
2
Purification and characterization of a novel heparinase.
J Biol Chem. 1990 Aug 15;265(23):13609-17.
3
Purification, characterization and specificity of chondroitin lyases and glycuronidase from Flavobacterium heparinum.来自肝素黄杆菌的软骨素裂解酶和葡萄糖醛酸酶的纯化、特性及特异性
Biochem J. 1995 Dec 1;312 ( Pt 2)(Pt 2):569-77. doi: 10.1042/bj3120569.
4
Purification and characterization of heparinase from Flavobacterium heparinum.来自肝素黄杆菌的肝素酶的纯化及特性分析
J Biol Chem. 1985 Feb 10;260(3):1849-57.
5
Examination of the substrate specificity of heparin and heparan sulfate lyases.肝素和硫酸乙酰肝素裂解酶的底物特异性检测。
Biochemistry. 1990 Mar 13;29(10):2611-7. doi: 10.1021/bi00462a026.
6
Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy.来自肝素黄杆菌的肝素酶I和肝素酶II的纯化及底物特异性。通过13C核磁共振光谱分析肝素和硫酸乙酰肝素的降解产物。
J Biol Chem. 1990 Oct 5;265(28):16807-13.
7
Opposite effects of basic fibroblast growth factor and heparin on heparin/heparan sulfate degrading enzymes from Flavobacterium heparinum.碱性成纤维细胞生长因子和肝素对来自肝素黄杆菌的肝素/硫酸乙酰肝素降解酶的相反作用。
Biochem Mol Biol Int. 1996 Jul;39(4):823-31. doi: 10.1080/15216549600201921.
8
Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum.来自肝素黄杆菌的肝素酶I在大肠杆菌中的表达、纯化及特性研究
Biochem J. 1996 Apr 15;315 ( Pt 2)(Pt 2):589-97. doi: 10.1042/bj3150589.
9
Specificity studies on the heparin lyases from Flavobacterium heparinum.来自肝素黄杆菌的肝素裂解酶的特异性研究。
Biochemistry. 1993 Aug 17;32(32):8140-5. doi: 10.1021/bi00083a012.
10
Substrate specificity of the heparin lyases from Flavobacterium heparinum.来自肝素黄杆菌的肝素裂解酶的底物特异性。
Arch Biochem Biophys. 1993 Nov 1;306(2):461-8. doi: 10.1006/abbi.1993.1538.

引用本文的文献

1
Cloning, expression, and characterization of a heparinase III coupled with heparinase I for enzymatic depolymerization of heparin.用于肝素酶解聚的肝素酶III与肝素酶I偶联物的克隆、表达及特性研究
World J Microbiol Biotechnol. 2024 Dec 23;41(1):15. doi: 10.1007/s11274-024-04225-2.
2
Identification and characterization of a novel heparinase PCHepII from marine bacterium Puteibacter caeruleilacunae.从海洋细菌粘质沙雷氏菌中鉴定和表征新型肝素酶 PCHepII。
Sci Rep. 2023 Nov 17;13(1):20112. doi: 10.1038/s41598-023-47493-y.
3
Cloning, Expression, and Characterization of a Highly Stable Heparinase I from .
来自……的一种高度稳定的肝素酶I的克隆、表达及特性分析
Polymers (Basel). 2023 Apr 3;15(7):1776. doi: 10.3390/polym15071776.
4
PCV2 Uptake by Porcine Monocytes Is Strain-Dependent and Is Associated with Amino Acid Characteristics on the Capsid Surface.猪单核细胞对猪圆环病毒2型的摄取具有毒株依赖性,且与衣壳表面的氨基酸特征有关。
Microbiol Spectr. 2023 Jan 31;11(2):e0380522. doi: 10.1128/spectrum.03805-22.
5
Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors.硫连接糖聚合物的酶促合成作为乙酰肝素酶抑制剂。
Nat Commun. 2022 Dec 2;13(1):7438. doi: 10.1038/s41467-022-34788-3.
6
Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing.肝素模拟物作为COVID-19的潜在干预手段及其生物制造
Synth Syst Biotechnol. 2023 Mar;8(1):11-19. doi: 10.1016/j.synbio.2022.10.002. Epub 2022 Oct 23.
7
Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates.剖析3-O-硫酸化肝素和工程化硫酸乙酰肝素的结构与功能
Sci Adv. 2021 Dec 24;7(52):eabl6026. doi: 10.1126/sciadv.abl6026. Epub 2021 Dec 22.
8
A Surface Loop in the N-Terminal Domain of Heparin Lyase II is Important for Activity.肝素酶II N端结构域中的一个表面环对活性很重要。
J Appl Glycosci (1999). 2016 Feb 20;63(1):7-11. doi: 10.5458/jag.jag.JAG-2015_019. eCollection 2016.
9
Viruses Like Sugars: How to Assess Glycan Involvement in Viral Attachment.病毒与糖类:如何评估聚糖在病毒附着中的作用
Microorganisms. 2021 Jun 7;9(6):1238. doi: 10.3390/microorganisms9061238.
10
A Revised Structure for the Glycolipid Terminus of K5 Heparosan Capsular Polysaccharide.K5 肝烷糖醛酸聚糖荚膜多糖糖脂末端的修订结构。
Biomolecules. 2020 Nov 6;10(11):1516. doi: 10.3390/biom10111516.